Gilead Sciences officer proposes $469K share sale

The notice also lists a September 15, 2026 sale of 3,000 shares for $432,646.20 and an August 17, 2026 sale of 28,000 shares for $3,853,907.85.

Rhea-AI Filing Summary

Gilead Sciences officer Johanna Mercier reported a proposed sale of 3,000 common shares with an aggregate market value of $468,660. Morgan Stanley Smith Barney LLC is listed as broker, and NASDAQ as the market for the proposed sale. The shares are identified as performance shares acquired from the issuer on February 4, 2025.

Key Figures

Proposed sale: 3,000 common shares Aggregate market value: $468,660 Shares sold September 15, 2026: 3,000 shares +3 more

6 metrics

Proposed sale 3,000 common shares Johanna Mercier's proposed sale

Aggregate market value $468,660 Proposed sale

Shares sold September 15, 2026 3,000 shares Sale reported during the prior three months

Reported sale value September 15, 2026 $432,646.20 Sale reported during the prior three months

Shares sold August 17, 2026 28,000 shares Sale reported during the prior three months

Reported sale value August 17, 2026 $3,853,907.85 Sale reported during the prior three months

Key Terms

Rule 144, Performance Shares

2 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144."

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

Performance Shares financial

"Performance Shares | ISSUER"

Performance shares are a type of company stock given to executives or employees that only become theirs if the company meets specific goals, like hitting certain profits or growth targets. They motivate leaders to work toward the company’s success, because their additional shares depend on achieving these results.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many GILD shares did Johanna Mercier report she plans to sell?

Johanna Mercier reported a proposed sale of 3,000 common shares with an aggregate market value of $468,660. Morgan Stanley Smith Barney LLC is listed as broker, and NASDAQ is identified as the market.

What GILD shares did Johanna Mercier sell in the prior three months?

The notice lists a sale of 3,000 shares on September 15, 2026 for $432,646.20 and a sale of 28,000 shares on August 17, 2026 for $3,853,907.85.

How did Johanna Mercier acquire the GILD shares proposed for sale?

The shares are identified as performance shares acquired from the issuer on February 4, 2025.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 10/15/2026 - 04:22 PM EDT Accepted by SEC EDGAR 10/15/2026 - 04:22 PM EDT Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001782135
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	GILEAD SCIENCES, INC.
SEC File Number	000-19731
Address of Issuer	333 Lakeside Drive Foster City CALIFORNIA 94404
Phone	(650) 574-3000
Name of Person for Whose Account the Securities are To Be Sold	JOHANNA MERCIER
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	3000	468660.00	1239955155	10/15/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/04/2025	Performance Shares	ISSUER			3000	02/04/2025	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
JOHANNA MERCIER 333 Lakeside Drive Foster City CA 94404	Common	09/15/2026	3000	432646.20
JOHANNA MERCIER 333 Lakeside Drive Foster City CA 94404	Common	08/17/2026	28000	3853907.85

144: Remarks and Signature

Remarks
Date of Notice	10/15/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	02/20/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Johanna Mercier
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)